Entos Pharmaceuticals Inc.
$100,000.00 CAD
≈ 16 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- May 1, 2020 – December 31, 2020
- Reference
- nrc-cnrc:172-2020-2021-Q1-949210
Published purpose
This project utilizes the Entos Fusogenix DNA delivery platform to rapidly develop, validate, manufacture and deploy countermeasures to protect the majority of the Canadian population from SARS-CoV-2 infection and COVID-19 disease.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions